Pfizer
PFE
PFE
2,387 hedge funds and large institutions have $173B invested in Pfizer in 2019 Q1 according to their latest regulatory filings, with 132 funds opening new positions, 904 increasing their positions, 1,112 reducing their positions, and 111 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,387
Holders Change
-12
Holders Change %
-0.5%
% of All Funds
51.75%
Holding in Top 10
201
Holding in Top 10 Change
-126
Holding in Top 10 Change %
-38.53%
% of All Funds
4.36%
New
132
Increased
904
Reduced
1,112
Closed
111
Calls
$1.53B
Puts
$1.29B
Net Calls
+$241M
Net Calls Change
+$316M
Top Buyers
| 1 |
Capital World Investors
Los Angeles,
California
|
$6.3B |
| 2 |
Goldman Sachs
New York
|
$2.25B |
| 3 |
D.E. Shaw & Co
New York
|
$461M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
$3.56B |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$1.89B |
